Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rebecca Martin
Observed institution:
Molecular Templates (United States)
ORCID:
0000-0002-7977-1611
Observed ORCID:
0000-0002-7977-1611
OpenAlex ID:
A5001061469
Abstract 326: Engineered toxin bodies (ETBs) targeting Trop2
2022
·
Garrett L. Cornelison
, Adam Bartos
, et al.
·
Cancer Research
·
1
Preclinical Characterization of ADCT-241, an Exatecan-Based Antibody–Drug Conjugate against PSMA for the Treatment of Metastatic Castration-Resistant Prostate Cancer
2026
·
Asma Jabeen
, Ben Leatherdale
, et al.
·
Molecular Cancer Therapeutics
PDF
Abstract P4-08-18: Engineered Toxin Bodies Specific for TROP2 Positive Cancers
2023
·
Garrett L. Cornelison
, Ileana Pedraza
, et al.
·
Cancer Research
Abstract 3538: A CTLA-4 targeted ETB for Treg depletion shows favorable preclinical efficacy and safety
2022
·
Asis Sarkar
, Rebecca Martin
, et al.
·
Cancer Research
Show more works
View as search
Works count:
4
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type
